Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 01 04:00PM ET
179.13
Dollar change
+2.46
Percentage change
1.39
%
IndexS&P 500 P/E36.43 EPS (ttm)4.92 Insider Own0.07% Shs Outstand501.89M Perf Week-0.60%
Market Cap82.24B Forward P/E29.76 EPS next Y6.02 Insider Trans-11.26% Shs Float458.79M Perf Month18.28%
Income2.28B PEG3.49 EPS next Q1.33 Inst Own93.70% Short Float / Ratio0.66% / 1.64 Perf Quarter-6.96%
Sales8.37B P/S9.82 EPS this Y10.95% Inst Trans0.02% Short Interest3.02M Perf Half Y4.22%
Book/sh11.05 P/B16.21 EPS next Y11.17% ROA16.41% Target Price216.96 Perf Year16.21%
Cash/sh3.82 P/C46.89 EPS next 5Y10.45% ROE46.81% 52W Range140.76 - 194.99 Perf YTD22.23%
Dividend1.49 P/FCF55.12 EPS past 5Y20.76% ROI19.29% 52W High-8.13% Beta0.84
Dividend %0.83% Quick Ratio2.16 Sales past 5Y8.85% Gross Margin68.55% 52W Low27.26% ATR3.58
Employees13800 Current Ratio3.87 Sales Q/Q7.44% Oper. Margin36.44% RSI (14)61.59 Volatility1.60% 2.19%
OptionableYes Debt/Eq1.33 EPS Q/Q14.54% Profit Margin27.24% Rel Volume0.74 Prev Close176.67
ShortableYes LT Debt/Eq1.33 EarningsNov 02 BMO Payout30.04% Avg Volume1.84M Price179.13
Recom1.47 SMA203.71% SMA504.71% SMA2002.91% Volume1,367,199 Change1.39%
Date Action Analyst Rating Change Price Target Change
Sep-06-23Initiated HSBC Securities Buy $230
Jul-12-22Initiated Piper Sandler Overweight $205
Nov-18-21Initiated Morgan Stanley Overweight $40
Nov-18-21Initiated Morgan Stanley Overweight $264
Aug-05-21Resumed Credit Suisse Outperform $206
Jul-16-21Downgrade Raymond James Outperform → Mkt Perform
Mar-08-21Upgrade Raymond James Mkt Perform → Outperform $166
Mar-08-21Upgrade BofA Securities Neutral → Buy $180
Sep-21-20Initiated Atlantic Equities Overweight $191
Aug-14-20Upgrade Edward Jones Hold → Buy
Nov-30-23 02:30PM
Nov-22-23 07:43PM
Nov-21-23 08:30AM
Nov-14-23 06:03AM
Nov-13-23 09:57PM
03:49AM Loading…
Nov-09-23 03:49AM
Nov-03-23 10:00AM
01:09AM
12:10AM
Nov-02-23 05:00PM
03:26PM
02:30PM
12:51PM
12:13PM
08:52AM
08:41AM Loading…
08:41AM
07:22AM
07:00AM
Oct-31-23 10:01AM
Oct-30-23 04:35PM
Oct-27-23 04:28PM
02:23PM
Oct-26-23 11:40AM
10:21AM
10:02AM
Oct-17-23 04:57PM
Oct-12-23 04:15PM
Oct-11-23 06:15AM
Oct-10-23 01:35PM
11:40AM
12:10PM Loading…
Oct-06-23 12:10PM
Oct-03-23 09:00AM
Sep-27-23 08:37AM
08:30AM
08:00AM
Sep-26-23 12:08PM
Sep-24-23 07:10PM
Sep-20-23 03:00AM
Sep-19-23 01:31PM
Sep-15-23 06:29PM
Sep-13-23 11:40AM
09:55AM
Sep-12-23 05:11PM
06:40AM
Sep-09-23 07:01AM
Sep-07-23 11:30AM
07:45AM
07:00AM
Sep-06-23 04:30PM
Aug-31-23 10:53PM
Aug-30-23 02:07PM
Aug-29-23 06:24PM
Aug-28-23 12:08PM
11:40AM
Aug-25-23 08:44AM
Aug-24-23 02:32PM
Aug-23-23 11:40AM
09:26AM
Aug-22-23 12:37PM
Aug-17-23 03:00PM
Aug-11-23 12:18PM
12:18PM
Aug-10-23 11:40AM
Aug-09-23 06:33PM
02:18PM
11:40AM
Aug-08-23 11:17PM
04:09PM
02:30PM
01:58PM
12:37PM
10:48AM
10:30AM
09:20AM
09:16AM
08:15AM
07:16AM
07:00AM
Aug-04-23 01:17PM
Aug-03-23 07:15AM
Aug-01-23 07:57AM
Jul-29-23 09:30AM
Jul-27-23 05:00AM
Jul-26-23 02:17PM
01:39PM
08:30AM
Jul-25-23 04:33PM
03:31PM
03:18PM
Jul-24-23 03:48AM
Jul-23-23 07:31PM
08:00AM
Jul-19-23 05:27AM
Jul-17-23 07:42AM
07:42AM
Jul-16-23 10:00AM
Jul-12-23 08:00AM
08:00AM
Jul-11-23 11:40AM
Jul-10-23 08:00AM
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The United States segment is involved in U.S. market and regulatory activities. The International segment includes non-U.S. market and regulatory activities. The company was founded in 1952 and is headquartered in Parsippany, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PECK KRISTIN CChief Executive OfficerNov 21Option Exercise46.0913,000599,17069,843Nov 21 04:41 PM
PECK KRISTIN CChief Executive OfficerNov 21Sale176.8413,0002,298,85656,843Nov 21 04:41 PM
Lagano RoxanneExecutive Vice PresidentNov 17Sale177.46923163,79622,665Nov 20 04:45 PM
Lagano RoxanneExecutive Vice PresidentOct 18Sale172.92923159,60523,588Oct 19 04:07 PM
Lagano RoxanneExecutive Vice PresidentSep 18Sale179.58923165,75224,511Sep 18 04:25 PM
Chen Heidi C.Executive Vice PresidentSep 15Sale180.159,9051,784,38627,478Sep 18 04:15 PM
Lagano RoxanneExecutive Vice PresidentSep 01Sale192.97923178,11125,434Sep 05 05:04 PM
PECK KRISTIN CChief Executive OfficerAug 22Option Exercise45.3513,000589,58569,843Aug 22 04:21 PM
PECK KRISTIN CChief Executive OfficerAug 22Sale179.9713,0002,339,56456,843Aug 22 04:21 PM
Polzer Robert JExecutive Vice PresidentAug 09Option Exercise144.031,179169,8113,532Aug 11 04:32 PM
Polzer Robert JExecutive Vice PresidentAug 09Sale189.941,179223,9392,353Aug 11 04:32 PM
PECK KRISTIN CChief Executive OfficerMay 23Option Exercise41.8313,000543,79069,843May 25 04:13 PM
PECK KRISTIN CChief Executive OfficerMay 23Sale176.5613,0002,295,33556,843May 25 04:13 PM
Lagano RoxanneExecutive Vice PresidentApr 18Option Exercise79.854,338346,39830,695Apr 19 04:18 PM
Lagano RoxanneExecutive Vice PresidentApr 18Sale175.944,338763,22826,357Apr 19 04:18 PM
Lagano RoxanneExecutive Vice PresidentFeb 14Option Exercise79.8513,0101,038,84339,367Feb 16 04:18 PM
Lagano RoxanneExecutive Vice PresidentFeb 14Sale175.0013,0102,276,75026,357Feb 16 04:18 PM